New drug aims to supercharge immune system against Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase trial is testing a new drug called INI-4001, which is designed to activate the immune system to fight advanced solid tumors. About 50 adults with cancers that have spread or cannot be removed will receive the drug alone or combined with standard immunotherapy dru…
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC